Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States. [electronic resource]
Producer: 20171204Description: 157-166 p. digitalISSN:- 1879-1891
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Bevacizumab -- administration & dosage
- Female
- Humans
- Intravitreal Injections
- Male
- Prevalence
- Ranibizumab -- administration & dosage
- Retrospective Studies
- United States -- epidemiology
- Visual Acuity
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.